How severe is CVE-2022-48226?

CVE-2022-48226 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.

Is CVE-2022-48226 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (8th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2022-48226?

CVE-2022-48226 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2022-48226?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.

When was CVE-2022-48226 published?

CVE-2022-48226 was published on 2023-04-04 and last updated on 2026-06-17.

CVE-2022-48226

CVE-2022-48226 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk with a CVSS 3.x base score of 7.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-269.

Key facts

Severity: High (CVSS 3.x base score 7.8)
EPSS exploit prediction: 0% (8th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-269
Affected product: Gbgplc Acuant Acufill Sdk
Published: 2023-04-04
Last modified: 2026-06-17

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.

Frequently asked questions

What is CVE-2022-48226?: An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.
How severe is CVE-2022-48226?: CVE-2022-48226 has a CVSS 3.x base score of 7.8, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-48226 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (8th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-48226?: CVE-2022-48226 affects Gbgplc Acuant Acufill Sdk. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2022-48226?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2022-48226 published?: CVE-2022-48226 was published on 2023-04-04 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:*

More vulnerabilities in Gbgplc Acuant Acufill Sdk

CVE-2022-48222 — High (CVSS 7.8): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK installation, certutil.exe is called by…
CVE-2022-48221 — High (CVSS 7.5): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user…
CVE-2022-48224 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is installed with insecure permissions (full write…
CVE-2022-48225 — High (CVSS 7.3): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. It is used to install drivers from several different…
CVE-2022-48223 — Medium (CVSS 6.7): An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the…

All CVEs affecting Gbgplc Acuant Acufill Sdk →

Other CWE-269 (Improper Privilege Management) vulnerabilities

CVE-2026-31852 — Critical (CVSS 10.0): Jellyfin is an open-source media system. The code-quality.yml GitHub Actions workflow in jellyfin/jellyfin-ios is…
CVE-2025-20282 — Critical (CVSS 10.0): A vulnerability in an internal API of Cisco ISE and Cisco ISE-PIC could allow an unauthenticated, remote attacker to…
CVE-2025-0505 — Critical (CVSS 10.0): On Arista CloudVision systems (virtual or physical on-premise deployments), Zero Touch Provisioning can be used to gain…
CVE-2023-48418 — Critical (CVSS 10.0): In checkDebuggingDisallowed of DeviceVersionFragment.java, there is a possible way to access adb before SUW…
CVE-2023-48419 — Critical (CVSS 10.0): An attacker in the wifi vicinity of a target Google Home can spy on the victim, resulting in Elevation of Privilege
CVE-2023-31273 — Critical (CVSS 10.0): Protection mechanism failure in some Intel DCM software before version 5.2 may allow an unauthenticated user to…

Browse all CWE-269 (Improper Privilege Management) vulnerabilities →